Tecvayli 153 MG/1.7 ML vial 1.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KD2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,258
Award facts
- Contract value 100% obligated
- $27,257.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,257.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TECVAYLI 153 mg/1.7 mL vials on January 7, 2026, with an ultimate completion date of January 29, 2026. This non-set-aside award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TECVAYLI (teclistamab) is a monoclonal antibody therapeutic used in oncology treatment, and this delivery order represents a specific task order against a larger indefinite delivery contract vehicle.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2031. This prime IDC serves as the comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of prescription medications, specialty drugs, vaccines, medical supplies, and related commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The non-set-aside status reflects the competitive nature of AmerisourceBergen's federal pharmaceutical procurement capabilities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9KD2?
SPE2DR26F9KD2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KD2 worth?
The government has obligated $27,258 on SPE2DR26F9KD2.
Is contract SPE2DR26F9KD2 an order under another contract?
Yes. SPE2DR26F9KD2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KD2 competed?
The extent of competition for SPE2DR26F9KD2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award